MedPath

Efficacy of 3 times Effective Dose 95 vs 6 times Effective Dose 95 dose of Cisatracurium with Magnesium Sulphate for endotracheal intubation in patients undergoing general anaesthesia.

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/06/068788
Lead Sponsor
Aarupadai veedu medical college and hospital.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age group from 18 to 65 years

ASA I and ASA II

Elective surgeries under general anaesthesia

Exclusion Criteria

Patient refusal to participate in the study

Patients taking magnesium supplements

Patients with arrhythmias

Patients with neuromuscular diseases

Patients on beta blockers or antiarrhythmic drugs

Patients using medications that influence neuromuscular functions (e.g., calcium channel blockers, phenytoin, aminoglycosides)

Electrolytes abnormalities

Hepatic or renal insufficiency

Pregnant and breastfeeding women

Patients with known allergies to medications used in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath